Annual Net Margin
N/A
December 31, 2023
Summary
- PTIX annual net profit margin is not available.
Performance
PTIX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Margin
N/A
September 30, 2024
Summary
- PTIX quarterly net profit margin is not available.
Performance
PTIX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
PTIX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PTIX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Protagenic Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | -1208.24%(+2351.3%) | - |
| Sep 2011 | - | -36.69%(-62.6%) |
| Jun 2011 | - | -98.13%(+97.0%) |
| Mar 2011 | - | -49.81%(-52.2%) |
| Dec 2010 | -49.29%(+15.5%) | -104.20%(+163.0%) |
| Sep 2010 | - | -39.62%(-4.6%) |
| Jun 2010 | - | -41.54%(+47.5%) |
| Mar 2010 | - | -28.16%(-83.9%) |
| Dec 2009 | -42.66%(-58.0%) | -175.33%(+993.1%) |
| Sep 2009 | - | -16.04%(+40.1%) |
| Jun 2009 | - | -11.45%(+127.2%) |
| Mar 2009 | - | -5.04%(-99.0%) |
| Dec 2008 | -101.65%(+806.0%) | -509.53%(>+9900.0%) |
| Sep 2008 | - | -0.02%(-100.6%) |
| Jun 2008 | - | 3.39%(-464.5%) |
| Mar 2008 | - | -0.93%(-86.2%) |
| Dec 2007 | -11.22%(-409.9%) | -6.75%(-63.7%) |
| Sep 2007 | - | -18.57%(+44.3%) |
| Jun 2007 | - | -12.87%(+95.3%) |
| Mar 2007 | - | -6.59%(-15.8%) |
| Dec 2006 | 3.62% | - |
| Apr 2006 | - | -7.83%(+12.2%) |
| Apr 2003 | - | -6.98%(-62.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2003 | - | -18.72%(+30.7%) |
| Oct 2002 | - | -14.32%(+37.2%) |
| Jul 2002 | -3.92%(-685.1%) | -10.44%(+176.2%) |
| Apr 2002 | - | -3.78%(-36.4%) |
| Jan 2002 | - | -5.94%(-315.2%) |
| Oct 2001 | - | 2.76%(-149.8%) |
| Jul 2001 | 0.67%(-87.4%) | -5.54%(-1485.0%) |
| Apr 2001 | - | 0.40%(-79.9%) |
| Jan 2001 | - | 1.99%(-68.1%) |
| Oct 2000 | - | 6.24%(+27.6%) |
| Jul 2000 | 5.31%(-247.9%) | 4.89%(+15.9%) |
| Apr 2000 | - | 4.22%(+11.9%) |
| Jan 2000 | - | 3.77%(-60.5%) |
| Oct 1999 | - | 9.55%(-157.4%) |
| Jul 1999 | -3.59%(-186.5%) | -16.64%(+248.1%) |
| Apr 1999 | - | -4.78%(-176.5%) |
| Oct 1998 | - | 6.25%(+408.1%) |
| Jul 1998 | 4.15%(-158.1%) | 1.23%(-81.6%) |
| Apr 1998 | - | 6.67%(-11.1%) |
| Oct 1997 | - | 7.50%(-201.2%) |
| Jul 1997 | -7.14% | -7.41%(-64.2%) |
| Jan 1997 | - | -20.69%(+582.8%) |
| Oct 1996 | - | -3.03% |
FAQ
- What is the all time high annual net margin for Protagenic Therapeutics?
- What is the all time high quarterly net margin for Protagenic Therapeutics?
What is the all time high annual net margin for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual net profit margin is 5.31%
What is the all time high quarterly net margin for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly net profit margin is 9.55%